Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirini Grigoriou

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomedicines|August 29, 2024
Erythropoietin Effect on Complement Activation in Chronic Kidney DiseaseVirginia Athanasiadou, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Virology|February 7, 2021
A novel ratio of CD8<sup>+</sup>:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcomeMaria G Detsika, Kleio Ampelakiotou, Eirini Grigoriou, et al.
In Vivo (Athens, Greece)|October 26, 2021
Combination of the CD8<sup>+</sup>:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 PatientsMaria G Detsika, Eirini Grigoriou, Katherina Psarra, et al.
Viruses|January 21, 2023
Kinetics of Immune Subsets in COVID-19 Patients Treated with CorticosteroidsApostolos Georgios Pappas, Anna-Louiza Chaliasou, Andreas Panagopoulos, et al.
Communications Biology|May 2, 2025
CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responsesMaria G Detsika, Maria Sakkou, Vassiliki Triantafyllidou, et al.
Journal of Clinical Pathology|December 8, 2019
Causes of double-negative T-cell lymphocytosis in children and adultsKonstantinos Liapis, Nikolaos J Tsagarakis, Fotis Panitsas, et al.
Leukemia & Lymphoma|April 6, 2019
Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidineMaria Tsirogianni, Eirini Grigoriou, Violetta Kapsimalli, et al.
European Journal of Clinical Investigation|January 17, 2022
Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvementAigli G Vakrakou, Lykourgos Kolilekas, Niki Lama, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicines|August 29, 2024
Erythropoietin Effect on Complement Activation in Chronic Kidney DiseaseVirginia Athanasiadou, Kleio Ampelakiotou, Eirini Grigoriou, et al.
Virology|February 7, 2021
A novel ratio of CD8<sup>+</sup>:B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcomeMaria G Detsika, Kleio Ampelakiotou, Eirini Grigoriou, et al.
In Vivo (Athens, Greece)|October 26, 2021
Combination of the CD8<sup>+</sup>:B-cell and Neutrophil-to-Lymphocyte Ratio as a Novel Prediction Model for Intubation Need and Disease Severity in COVID-19 PatientsMaria G Detsika, Eirini Grigoriou, Katherina Psarra, et al.
Viruses|January 21, 2023
Kinetics of Immune Subsets in COVID-19 Patients Treated with CorticosteroidsApostolos Georgios Pappas, Anna-Louiza Chaliasou, Andreas Panagopoulos, et al.
Communications Biology|May 2, 2025
CD55 upregulation in T cells of COVID-19 patients suppresses type-I interferon responsesMaria G Detsika, Maria Sakkou, Vassiliki Triantafyllidou, et al.
Journal of Clinical Pathology|December 8, 2019
Causes of double-negative T-cell lymphocytosis in children and adultsKonstantinos Liapis, Nikolaos J Tsagarakis, Fotis Panitsas, et al.
Leukemia & Lymphoma|April 6, 2019
Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidineMaria Tsirogianni, Eirini Grigoriou, Violetta Kapsimalli, et al.
European Journal of Clinical Investigation|January 17, 2022
Peripheral blood natural killer cells in sarcoidosis are associated with early cardiac involvementAigli G Vakrakou, Lykourgos Kolilekas, Niki Lama, et al.
Pageof 1